0 CHECKOUT

Phase 2 trial of ISIS 104838 for the treatment of Rheumatoid Arthritis - Isis Pharmaceuticals, Inc. - Earnings Transcript

  • ID: 732910
  • January 2004
  • FactSet
1 of 2

Phase 2 trial of ISIS 104838 for the treatment of Rheumatoid Arthritis - Isis Pharmaceuticals, Inc. - Earnings Transcript
Monday, January 05, 2004 03:00

Note: Product cover images may vary from those shown
2 of 2
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.